JP Morgan Healthcare Conference, Day 4: Cepheid, Fluidigm | GenomeWeb

By a GenomeWeb staff reporter

SAN FRANCISCO (GenomeWeb News) – The JP Morgan Healthcare Conference wrapped up on Thursday with a handful of life science tools and molecular diagnostics companies presenting to investors, including Sequenom, which spoke about its goal to bill 25,000 MaterniT21 tests in 2012.

Below are capsules of presentations from two other companies that presented on the fourth day of the conference.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.